Latest Insights - page 3 | BiopharmaTrend

Anthropic Pays $400M for an AI Biotech With Fewer Than Ten People

Anthropic is reported to have acquired Coefficient Bio, a recently founded AI-driven biotech startup with a team of less than ten people, in a transaction valued at approximately $400 million …

Continue ›››

Everyone is Launching AI Agents. What's Being Deployed?

A deep dive on the next cycle of biopharma's AI buildout Last year's "growing buzz around AI agents" that we surveyed has since grown into a full avalanche of infrastructure …

Continue ›››

Epia Neuro Wants to Decode Brain's Movement Intentions After Stroke

A San Francisco startup Epia Neuro launched today with a minimally invasive brain-computer interface (BCI) designed to help stroke survivors regain motor function by reading what the brain intends to …

Continue ›››

Generare Raises €20M to Explore Uncharacterized Chemical Space from Microbial DNA

Paris-based techbio Generare has raised €20 million in a Series A round co-led by Alven and daphni, with participation from existing investors. The company is focused on generating previously inaccessible …

Continue ›››

Enveda’s AI-Discovered Drug Shows Early Atopic Dermatitis Relief

After reporting the first patient dosed in September 2025, early clinical data from a small open-label study indicate that Enveda’s oral candidate, discovered via the company’s PRISM AI platform, ENV-294, …

Continue ›››

Lilly Signs $2.75B AI Drug Discovery Deal With Insilico

Insilico Medicine and Eli Lilly have entered a multi-program AI-driven drug discovery collaboration, combining Insilico’s generative modeling platforms with Lilly’s clinical and commercialization infrastructure. Under the agreement, Insilico receives $115 …

Continue ›››

Meta Open Sources Foundation Model That Predicts Brain Responses to Speech, Video, and Text

Meta has released TRIBE v2, an open-source foundation model designed to predict human brain responses to visual and auditory stimuli and construct a digital twin of neural activity. The model …

Continue ›››

Two Ex-GSK AI Leads Go Stealth with a New Oncology Drug Discovery Startup

Clockwork Bio has been launched as a new AI-native biotech focused on redesigning early-stage oncology drug discovery. The company is developing a platform centered on modeling and controlling cell state …

Continue ›››

Tempus and Daiichi Sankyo Partner on AI-Guided Cancer Biomarker Discovery

Tempus and Daiichi Sankyo have entered a collaboration to apply multimodal AI models and real-world clinical data to an oncology antibody-drug conjugate (ADC) program. The effort centers on improving patient …

Continue ›››

Bioptimus Launches Multimodal Tissue Atlas Across Three Continents

Bioptimus launched the Spatial Tissue Embedding Learning Atlas (STELA), a large-scale, clinically linked multimodal dataset spanning oncology and immunology. The global initiative, spanning data from patients from three continents, was …

Continue ›››

Merck Signs $20M Deal With Quotient to Find IBD Targets Using Somatic Genomics

Merck has entered a discovery collaboration with Quotient Therapeutics, committing $20 million upfront to access Somatic Genomics, an AI-enabled platform that analyzes somatic mutations directly in patient tissues. The agreement …

Continue ›››

insitro and Bristol Myers Squibb Add New AI-Found Targets in ALS Research

The ongoing collaboration between insitro and Bristol Myers Squibb has been extended to include additional AI-discovered therapeutic targets for amyotrophic lateral sclerosis (ALS), with early experimental validation in human neuron …

Continue ›››